Test Price
2,800 AED✅ Home Collection Available
CSF1 Gene Osteogenesis and Dental Anomalies Genetic Test in UAE | 2800 AED
Executive Summary & Core Metrics
- Diagnostic Accuracy: 99.9% sensitivity and specificity via ISO 9001:2015 certified next‑generation sequencing (NGS).
- Premium Logistics: VIP mobile phlebotomy and temperature‑controlled cold‑chain home collection – available daily 8 AM‑11 PM.
- Post‑Test Support: Complimentary telephonic genetic counselling for result interpretation and clinical guidance.
- Insurance Verification: Direct billing assistance via WhatsApp +971 54 548 8731.
Test Overview & Methodology
This next‑generation sequencing (NGS) assay comprehensively evaluates the entire coding region and exon‑intron boundaries of the CSF1 gene, providing a molecular diagnosis for autosomal recessive osteopetrosis, dental anomalies, and associated pigmentation disorders. With a turnaround time of 3‑4 weeks, the test delivers 99.9% analytical sensitivity and specificity, performed in a DHA‑licensed facility under strict ISO 9001:2015 quality standards.
| Feature | Our NGS Test | Closest Alternative (Sanger) |
|---|---|---|
| Test Coverage | Full gene & flanking regions | Selected exons only |
| Analytical Sensitivity | 99.9% | ~95% |
| Turnaround Time | 3 – 4 weeks | 6 – 8 weeks |
| Copy Number Variant Detection | Yes | Limited |
| Home Collection (cold chain) | Included | Not available |
Physician Insight & Safety Protocols
“A confirmed molecular diagnosis of CSF1‑related disorders empowers families to access targeted therapies and anticipatory care. This NGS test provides high‑resolution data crucial for accurate management. I strongly recommend pre‑ and post‑test genetic counselling to contextualise findings and ensure all safety measures are observed.”
– Lina Osama Zaki Quteineh, Consultant Medical Genetics (DHA ID: 9294403)
Medication & Safety Advisory
Important
Do not discontinue any prescribed medication without prior consultation with your treating physician. Some drugs may influence test interpretation or pose risks during the blood collection procedure.
Exclusion Criteria & Emergency Red Flags
- Minors under 12 years require written consent from a legal guardian and paediatric genetic counselling.
- Active systemic infection or blood transfusion within the last 2 weeks may compromise sample purity.
- Pregnancy is not an absolute contraindication; however, post‑test counselling should address prenatal implications.
- Seek emergency care if you experience excessive bleeding, expanding haematoma, high fever, or signs of allergic reaction following the blood draw.
Patient FAQ & Clinical Guidance
1. What conditions does the CSF1 gene test detect?
This test identifies pathogenic variants in the CSF1 gene associated with autosomal recessive osteopetrosis, dental anomalies (delayed eruption, hypodontia), and pigmentation abnormalities (skin hyperpigmentation). It confirms a molecular diagnosis and guides referral to specialists in bone metabolism, dentistry, and dermatology.
2. How is the sample collected?
A standard venous blood draw (3–5 mL) or a dried blood spot on an FTA card is obtained by a DHA‑licensed phlebotomist. For home collection, our VIP mobile phlebotomy service uses temperature‑controlled cold‑chain transport to preserve DNA integrity. Alternatively, previously extracted DNA can be submitted.
3. How long until I receive the results, and what support is provided?
Results are typically available within 3–4 weeks. A comprehensive report with variant classification and clinical recommendations is provided, accompanied by a telephonic genetic counselling session to interpret the findings and discuss next steps.
UAE Regulatory & Data Privacy Adherence
- Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) – All personal and genetic data are stored on encrypted, HIPAA‑aligned servers with access restricted to authorised clinical personnel only.
- Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields – Ensures secure electronic transmission and storage of health information.
- Federal Decree‑Law No. 4 of 2016 on Medical Liability – Governs informed consent and clinical safety standards for diagnostic procedures.
- ISO 9001:2015 Certified – Certificate No. INT/EGQ/2509DA/3139, DHA Facility License 1143.
Clinical & Logistical Metadata
| Test Name | CSF1 Gene Osteogenesis and Dental Anomalies Genetic Test |
| Price (AED) | 2,800 |
| Turnaround Time | 3–4 weeks |
| Sample Type / Matrix | Peripheral whole blood (venous) or dried blood spot (FTA card). VIP mobile phlebotomy and cold-chain home collection available daily 8 AM–11 PM. |
| Methodology Used | Next‑Generation Sequencing (NGS) – full gene coding region and exon‑intron boundaries |
| ICD-10-CM Code | M85.8 (Osteopetrosis), K00.8 (Dental anomalies), L81.9 (Pigmentation disorder) |
| LOINC Code | 21684-6 (DNA mutation analysis, whole genome) |
| DHA Facility License & Laboratory Address | DHA License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians